Canada Life’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Canada Life’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,882	Closed	-$79K	–	2567
2021 Q3	$79K	Hold	3,882	–	–	﹤0.01%	2109
2021 Q2	$145K	Hold	3,882	–	–	﹤0.01%	2009
2021 Q1	$98K	Hold	3,882	–	–	﹤0.01%	2105
2020 Q4	$85K	Hold	3,882	–	–	﹤0.01%	2151
2020 Q3	$70K	Hold	3,882	–	–	﹤0.01%	2109
2020 Q2	$98K	Hold	3,882	–	–	﹤0.01%	2049
2020 Q1	$72K	Hold	3,882	–	–	﹤0.01%	2045
2019 Q4	$85K	Buy	+3,882	New	+$78.1K	﹤0.01%	2113
2019 Q3	–	Sell	-5,077	Closed	-$80K	–	2556
2019 Q2	$80K	Hold	5,077	–	–	﹤0.01%	2297
2019 Q1	$74K	Hold	5,077	–	–	﹤0.01%	2161
2018 Q4	$52K	Hold	5,077	–	–	﹤0.01%	2362
2018 Q3	$77K	Hold	5,077	–	–	﹤0.01%	2279
2018 Q2	$62K	Buy	+5,077	New	+$63.8K	﹤0.01%	2358

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Canada Life's DRNA Position: Q4 2021 in Review

Canada Life sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,882 shares — an estimated $79K sold.

Canada Life first reported a position in DRNA in Q2 2018 and held it in 13 quarters. The position peaked at $145K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Canada Life reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Canada Life sold 3,882 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $79K.
Canada Life first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 13 quarters.
Canada Life's Dicerna Pharmaceuticals, Inc. position peaked at $145K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.